With Dr. Michelle Tarver’s appointment as the new director of CDRH, BISA hopes for stronger patient-focused oversight, contrasting with past controversies.

Maria Gmitro, president of Breast Implant Safety Alliance (BISA) BISA was recently quoted in The New York Times regarding the announcement of Dr. Michelle Tarver as the new FDA CDRH Director.

Interested in who we are, what we do and why we do it? This presentation will help you understand how we want to keep women safe, healthy and informed.

The 3rd Breast Implant Health Symposium is a virtual event designed for healthcare practitioners to discuss assessing and treating patients with breast implants on November 2 and 3, 2024.

Whether it’s implants, flap reconstruction, or opting for a flat chest with aesthetic flat closure, the point is: it’s your body, your rules. But here’s the catch: some doctors didn’t seem to get the message.

BISA continues to empower women in local communities on breast cancer and breast implant safety with the 2nd "Knowledge is Beautiful" Awareness Event in Oregon.

The FDA welcomes participation during the October 30, 2024 Patient Engagement Advisory Committee (PEAC) meeting on patient-centered informed consent in clinical study of FDA-regulated medical products.

BISA wants to keep women healthy, safe, and informed. Here are 5 important things all women should know about breast implants.

In a recent podcast episode, author Mel Robbins shared her breast implant story. Many of BISA’s members can relate to her story. Can you?

In honor of Breast Cancer Awareness Month, the 2nd Annual “Knowledge is Beautiful” Awareness & Fundraiser Event is being held on Wednesday, October 16th in Bend, Oregon led by women's health advocate Sherri Gorbett.

The FDA has approved Motiva’s SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants for breast augmentation in people 22 and older.

BISA Founder Maria Gmitro and VP Sarah Beckcom attended the Women's Health Innovation Summit with over 600 attendees, 30+ investors and 3 days of phenomenal content focused on addressing the unique health needs of women.

Our collaborator, Dr. Siham Azahaf, is a breast implant illness researcher in Amsterdam, the Netherlands. She’s also a medical advisor for BISA Nonprofit and the author of many scientific papers.

BISA members who have earned the BCPA certification describe their experience, along with the professional and ethical benefits of additional patient advocacy education.

BISA worked improve the FDA’s Advisory Committee process by speaking at a recent listening session, along with a post-meeting with the Federation of American Scientists to discuss next steps.

We the Patients 2024, organized by Patients Rising, featured nearly 60 advocates visiting Washington, D.C. to engage with 70 congressional offices about policy issues for people living with chronic and life-threatening illnesses.

In June 2024, BISA joined the Komen Foundation on Capitol Hill for the second time to support advocates sharing breast cancer stories with members of Congress at the Susan G. Komen Advocacy Summit.

Members of BISA collaborated to create a consensus statement on breast implant capsulectomy definitions and management as part of the Breast Surgery Collaborative Community (BSCC).

BISA released the May 2024 Life Letter with a recap from last month and some brief updates on what’s next.

BISA summarizes what we learned from the 5th World Consensus Conference on BIA-ALCL on April 20, 2024.